Back to CVE records
Low 2.1Published Aug 21, 2026

CVE-2026-48590Element and Attribute Names Injected Verbatim into XML Output in xml_builder

Updated under an hour ago ()

Does this affect you?

It affects joshnuss xml_builder. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

XML Injection vulnerability in joshnuss xml_builder (XmlBuilder module) allows Content Spoofing, XML Injection. This vulnerability is associated with program files lib/xml_builder.ex and program routines XmlBuilder.generate/1, XmlBuilder.generate/2, XmlBuilder.element/1, XmlBuilder.element/2, XmlBuilder.element/3. Element names, attribute names, and doctype identifiers are interpolated verbatim into the serialized XML output without validation or escaping of structural characters (<, >, ", ', &). An attacker who can influence a name argument (for example, an element name derived from a JSON object key or an HTTP form field name) can inject arbitrary XML markup including extra elements, comments, and event-handler attributes into the output document. This issue affects xml_builder: from 0.0.1 before 2.4.1.

CVSS
2.1 LOW (v4.0, CNA)CVSS:4.0/AV:L/AC:L/AT:P/PR:N/UI:N/VC:N/VI:N/VA:N/SC:N/SI:L/SA:N
Weakness (CWE)
CWE-91
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
EEF
NVD analysis
Awaiting Analysis
Record last updated
Aug 21, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
joshnuss xml_builder
joshnuss:xml_builder
from 0.0.1 before 2.4.1
CNA record

References

  • vendor-advisory, related
  • related
  • related
  • patch

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.